Stock listing

Ltr Pharma Limited

Selected listing: LTP · ASX · AUD · AU

Ltr Pharma Limited (ASX:LTP), Health Technology. Latest release Oct 5, 2026: First ROXUS Prescriptions Fulfilled in the United States.

LTP:ASXAUDAUUpdated October 2, 2026
Ltr Pharma Limited logo
Ticker
ASX:LTP
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

About Ltr Pharma Limited

Ltr Pharma Limited, trading under the ticker LTP, is a public company listed on the Australian market. Ltr Pharma focuses on developing innovative pharmaceutical solutions.

Latest news from Ltr Pharma Limited

First ROXUS Prescriptions Fulfilled in the United States

October 5, 2026

SPONTAN Phase II Final Results

September 30, 2026

FY26 Results Announcement

August 27, 2026

SPONTAN Real-World Study Reports 93% Response

August 10, 2026

LTR Executes U.S. Commercial Agreement with Strive

July 19, 2026

All Ltr Pharma Limited news →

Research Ltr Pharma Limited

Ltr Pharma Limited company profile

View the public company page for Ltr Pharma Limited on 6ix.

Ltr Pharma Limited news

Read company news and market updates connected to Ltr Pharma Limited.

Ltr Pharma Limited investor events

Find investor webinars, events, and replay context for Ltr Pharma Limited.

Alternate listings

LTPLF:OTC

US · USD

Alternate listing for Ltr Pharma Limited; the primary context on this page is LTP:ASX.